{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:23:34Z","timestamp":1791318214185,"version":"4.3.1"},"update-to":[{"DOI":"10.1016\/j.ymthe.2021.10.005","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000}}],"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2019B121205005"],"award-info":[{"award-number":["2019B121205005"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018801","name":"Lui Che Woo Institute of Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1601227"],"award-info":[{"award-number":["U1601227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ymthe.2021.10.005","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T05:18:24Z","timestamp":1633756704000},"page":"881-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["RETRACTED: Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction"],"prefix":"10.1016","volume":"30","author":[{"given":"Yu-Yan","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9510-9778","authenticated-orcid":false,"given":"Wenjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-1672","authenticated-orcid":false,"given":"Song","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-9755","authenticated-orcid":false,"given":"Hui-Yao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.10.005_bib1","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.113.003668","article-title":"National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010","volume":"128","author":"Chen","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2021.10.005_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s11606-014-2862-5","article-title":"National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia: update on publicly reported outcomes measures based on the 2013 release","volume":"29","author":"Suter","year":"2014","journal-title":"J.\u00a0Gen. Intern. Med."},{"key":"10.1016\/j.ymthe.2021.10.005_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yjmcc.2016.05.002","article-title":"Molecular networks underlying myofibroblast fate and fibrosis","volume":"97","author":"Stempien-Otero","year":"2016","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12929-017-0322-3","article-title":"Macrophage activation and polarization in post-infarction cardiac remodeling","volume":"24","author":"Gombozhapova","year":"2017","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ymthe.2021.10.005_bib5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0735-1097(03)01057-X","article-title":"Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study","volume":"42","author":"Lewis","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMe1112770","article-title":"A new era in secondary prevention after acute coronary syndrome","volume":"366","author":"Roe","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.10.005_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.10.005_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: A stressful review","volume":"55","author":"Reichmann","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ymthe.2021.10.005_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.103.051227","article-title":"The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction","volume":"306","author":"Berglund","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2021.10.005_bib10","doi-asserted-by":"crossref","first-page":"C1271","DOI":"10.1152\/ajpcell.1994.266.5.C1271","article-title":"Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes","volume":"266","author":"Millar","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2016.06.138","article-title":"The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease","volume":"220","author":"Zhu","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1050-1738(02)00232-3","article-title":"Neuropeptide Y: a novel mechanism for ischemic angiogenesis","volume":"13","author":"Zukowska","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ymthe.2021.10.005_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2017.07.011","article-title":"Is NPY causing myocardial ischemia in patients with microvascular angina associated with its abnormal constrictor response at the microcirculation level?","volume":"247","author":"Zhao","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.yjmcc.2012.08.027","article-title":"Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia","volume":"53","author":"Matyal","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The Role of Neuropeptide Y in Cardiovascular Health and Disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib16","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2174\/156802607782340939","article-title":"NPY and cardiac diseases","volume":"7","author":"McDermott","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ymthe.2021.10.005_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00726-011-1185-7","article-title":"The intriguing mission of neuropeptide Y in the immune system","volume":"45","author":"Dimitrijevi\u0107","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.ymthe.2021.10.005_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12264-008-0130-6","article-title":"Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor","volume":"24","author":"Zhou","year":"2008","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ymthe.2021.10.005_bib19","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1096\/fj.13-243485","article-title":"Neuropeptide Y induces potent migration of human immature dendritic cells and promotes a Th2 polarization","volume":"28","author":"Buttari","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2021.10.005_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.peptides.2006.09.030","article-title":"The Y1 receptor for NPY: a key modulator of the adaptive immune system","volume":"28","author":"Wheway","year":"2007","journal-title":"Peptides"},{"issue":"9B","key":"10.1016\/j.ymthe.2021.10.005_bib21","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1111\/j.1582-4934.2009.00707.x","article-title":"Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction","volume":"13","author":"Troidl","year":"2009","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2021.10.005_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/BJ20131501","article-title":"Involvement of monocytes\/macrophages as key factors in the development and progression of cardiovascular diseases","volume":"458","author":"Fern\u00e1ndez-Velasco","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2021.10.005_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/CIRCRESAHA.115.303567","article-title":"Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction","volume":"115","author":"Heidt","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2021.10.005_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/CIRCRESAHA.113.300890","article-title":"Monocyte and macrophage heterogeneity in the heart","volume":"112","author":"Nahrendorf","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2021.10.005_bib25","doi-asserted-by":"crossref","first-page":"367245","DOI":"10.1155\/2013\/367245","article-title":"Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome","volume":"2013","author":"Asrih","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2021.10.005_bib26","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.hjh.0000388493.81578.b1","article-title":"The role of nuclear factor kappa B and nitric oxide interaction in heart remodelling","volume":"28","author":"Pechanova","year":"2010","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ymthe.2021.10.005_bib27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0002-8703(94)90543-6","article-title":"Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction","volume":"127","author":"Omland","year":"1994","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2021.10.005_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1749-6632.1995.tb44683.x","article-title":"Neuropeptide Y. A novel sympathetic stress hormone and more","volume":"771","author":"Zukowska-Grojec","year":"1995","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ymthe.2021.10.005_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2014.08.004","article-title":"Role of neuropeptides in cardiomyopathies","volume":"61","author":"Dvorakova","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.ymthe.2021.10.005_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/oxfordjournals.eurheartj.a060526","article-title":"Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction","volume":"15","author":"Ullman","year":"1994","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2021.10.005_bib31","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/eurheartj\/ehz115","article-title":"Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction","volume":"40","author":"Herring","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2021.10.005_bib32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/heartjnl-2012-303443","article-title":"Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction","volume":"99","author":"Cuculi","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.ymthe.2021.10.005_bib33","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/eurheartj\/ehz852","article-title":"The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade","volume":"41","author":"Kalla","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2021.10.005_bib34","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI114004","article-title":"Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs","volume":"83","author":"Maturi","year":"1989","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.10.005_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)90483-1","article-title":"Coronary artery infusion of neuropeptide Y in patients with angina pectoris","volume":"1","author":"Clarke","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2021.10.005_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2017.03.024","article-title":"Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina","volume":"238","author":"Rosano","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000430336","article-title":"Long-Term Administration of Neuropeptide Y in the Subcutaneous Infusion Results in Cardiac Dysfunction and Hypertrophy in Rats","volume":"37","author":"Zhang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2021.10.005_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejphar.2013.08.023","article-title":"Local infiltration of neuropeptide Y as a potential therapeutic agent against apoptosis and fibrosis in a swine model of hypercholesterolemia and chronic myocardial ischemia","volume":"718","author":"Matyal","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2016.02.033","article-title":"Neuropeptide Y is an angiogenic factor in cardiovascular regeneration","volume":"776","author":"Saraf","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib40","doi-asserted-by":"crossref","first-page":"H275","DOI":"10.1152\/ajpheart.00765.2009","article-title":"Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction","volume":"298","author":"Wang","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib41","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3389\/fphar.2019.01268","article-title":"Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCRESAHA.119.315069","article-title":"Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation","volume":"125","author":"Chen","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2021.10.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0269-4","article-title":"Macrophages in cardiac repair: Environmental cues and therapeutic strategies","volume":"51","author":"de Couto","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2021.10.005_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000338500","article-title":"Neuropeptide Y reverses chronic stress-induced baroreflex hypersensitivity in rats","volume":"29","author":"Xie","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2021.10.005_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1742-2094-8-169","article-title":"Neuropeptide Y inhibits interleukin-1\u03b2-induced phagocytosis by microglial cells","volume":"8","author":"Ferreira","year":"2011","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2021.10.005_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yhbeh.2013.05.005","article-title":"Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-\u03baB-mediated feeding behavior in phenylpropanolamine-treated rats","volume":"64","author":"Hsieh","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ymthe.2021.10.005_bib47","doi-asserted-by":"crossref","first-page":"580378","DOI":"10.3389\/fimmu.2020.580378","article-title":"Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2021.10.005_bib48","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.peptides.2008.08.017","article-title":"The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age","volume":"29","author":"Dimitrijevi\u0107","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ymthe.2021.10.005_bib49","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.2337\/db12-0156","article-title":"Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity","volume":"61","author":"Macia","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2021.10.005_bib50","doi-asserted-by":"crossref","first-page":"e57929","DOI":"10.1371\/journal.pone.0057929","article-title":"Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation","volume":"8","author":"Singer","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.10.005_bib51","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.109.147611","article-title":"Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling","volume":"55","author":"Huang","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ymthe.2021.10.005_bib52","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ymthe.2018.07.014","article-title":"Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice","volume":"26","author":"Li","year":"2018","journal-title":"Mol. Ther."}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2023.12.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000}},{"DOI":"10.1016\/j.ymthe.2026.04.048","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000}},{"DOI":"10.1016\/j.ymthe.2021.10.005","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000}},{"DOI":"10.1016\/j.ymthe.2023.12.013","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000}},{"DOI":"10.1016\/j.ymthe.2026.04.048","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621004998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621004998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:46:55Z","timestamp":1777618015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621004998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1525001621004998"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.10.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}